Quantcast
Last updated on April 18, 2014 at 6:30 EDT
Silly Putty Ingredient Could Help Stem Cells Become Motor

Silly Putty Ingredient Could Help Stem Cells Become Motor Neurons

redOrbit Staff & Wire Reports - Your Universe Online An ingredient found in Silly Putty could help scientists more efficiently turn human embryonic stem cells into fully functional specialized cells, according to research published online...

Latest Stem cells Stories

2014-04-17 23:10:13

Drehsen claims excellent results in past procedures using stem cell techniques. St. Petersburg, FL (PRWEB) April 17, 2014 One of the most respected plastic surgeons in America is encouraging the FDA to move forward on approval of stem-cell based therapies — inspired in part by Matthew McConaughey's recent Oscar win for the film Dallas Buyers Club. In the film, McConaughey portrayed Ron Woodroof, who fought the Food and Drug Administration over his use and distribution of unapproved...

2014-04-17 14:30:27

Consider the marvel of the embryo. It begins as a glob of identical cells that change shape and function as they multiply to become the cells of our lungs, muscles, nerves and all the other specialized tissues of the body. Now, in a feat of reverse tissue engineering, Stanford University researchers have begun to unravel the complex genetic coding that allows embryonic cells to proliferate and transform into all of the specialized cells that perform myriad biological tasks. A team of...

2014-04-16 11:43:12

UC Irvine neurobiologists have found that genetically modified neural stem cells show positive results when transplanted into the brains of mice with the symptoms and pathology of Alzheimer's disease. The pre-clinical trial is published in the journal Stem Cells Research and Therapy, and the approach has been shown to work in two different mouse models. Alzheimer's disease, one of the most common forms of dementia, is associated with accumulation of the protein amyloid-beta in the brain in...

2014-04-16 08:34:35

NSI-566 to be Tested in Patients with Chronic Spinal Cord Injury ROCKVILLE, Md., April 16, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that the Institutional Review Board of the University of California, San Diego, School of Medicine has approved the Phase I safety trial to treat chronic spinal cord injury (cSCI) with its NSI-566 stem cells. The NSI-566/cSCI Phase I trial will enroll patients with thoracic spinal cord injuries (T2-T12) who have an American Spinal...

2014-04-15 23:06:52

International Leaders to Share Unparalleled Achievements in Stem Cell Research at DIA Annual Meeting Washington (PRWEB) April 15, 2014 Research that resulted in the first stem cells that are pluripotent—those that have the potential to differentiate into almost any cell in the body—will be the backdrop for a discussion about trends in regulation in the field of regenerative medicine at the DIA 2014 50th Annual Meeting, June 15 to 19 in San Diego. Chaired by Shinji Miyake, professor of...

2014-04-15 12:30:19

Dr. James Andrews, Respected Orthopedic Surgeon and Founding Member of American Sports Medicine Institute, To Serve as Principal Investigator BURLINGTON, Mass., April 15, 2014 /PRNewswire/ -- inVentiv Health Clinical, a leading global supplier of drug development services, announced today that it has been selected for an osteoarthritis Investigational New Drug Application (IND) by the innovative regenerative medicine biotechnology company IntelliCell BioSciences, Inc.,...

2014-04-15 08:30:55

SAN BRUNO, Calif., April 15, 2014 /PRNewswire/ -- Cord Blood Registry® (CBR®) announces the launch of an FDA-regulated clinical trial being conducted at The University of Texas Health Science Center at Houston to investigate two forms of stem cell therapy in children diagnosed with cerebral palsy. The randomized, placebo-controlled study aims to compare the safety and efficacy of an intravenous infusion of cord blood stem cells to bone marrow stem cells....

2014-04-14 23:04:25

The market for mice model services is segmented into breeding, cryopreservation, quarantine, rederivation, genetic testing, model in-licensing, and other services (surgical and line rescue); http://www.marketsandmarkets.com/Market-Reports/mice-model-market-1308.html. (PRWEB) April 14, 2014 This report studies “Mice Model Market - By Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding,...

2014-04-14 23:02:50

Transparency Market Research Report added "Human Embryonic Stem Cells Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019" to its database. Browse full report:- http://www.transparencymarketresearch.com/human-embryonic-stem-cells.html. Albany, NY (PRWEB) April 14, 2014 Human embryonic stem cells (hESCs) are derived from blastocyst and are capable of differentiating into number of cell types that make up the human body. hESCs can replicate...

2014-04-14 16:25:26

Americord Raises Standards of Customer Service in Cord Blood Industry NEW YORK, April 14, 2014 /PRNewswire/ -- Cord Blood Banking leader Americord today published a bill of rights it believes every cord blood banking client should expect to receive from their cord blood bank. Encompassing information as well as service, the "Cord Blood Banking Bill of Rights" covers fundamental issues such as transparency and equitable pricing and ensures that clients who are storing their cord...